Страна: Южна Африка
Език: английски
Източник: South African Health Products Regulatory Authority (SAHPRA)
Adcock
BURINEX® 1 mg Tablets BURINEX® 2 mg 0,5 mg/mL 4 mL Injection SCHEDULING STATUS: S3 PROPRIETARY NAME (and dosage form): BURINEX ® 1 mg Tablets BURINEX ® 2 mg 0,5 mg/mL 4 mL Injection COMPOSITION: Tablets: Each tablet contains 1 mg bumetanide . Injection: Each ampoule contains bumetanide 0,5 mg/mL in a neutral isotonic solution (phosphate buffer). PHARMACOLOGICAL CLASSIFICATION: A. 18.1 Diuretic PHARMACOLOGICAL ACTION: BURINEX ® (Bumetanide) is a potent high ceiling diuretic, with a rapid onset and a short duration of action. After oral administration, diuresis begins within thirty minutes with a peak effect between one and two hours. The diuretic effect is virtually complete in four to six hours. After intravenous injection, diuresis starts within a few minutes and generally ceases in about two hours. The diuretic effect produced by BURINEX ® is dose related so that patients who fail to respond to a low dose may respond as the dose is increased. BURINEX ® has been shown to exert its major effect in the ascending limb of the loop of Henle, but it may also have an additional action in the proximal tubule. BURINEX ® is a derivative of metanilamide and is chemically distinct from other available diuretics. Investigations in healthy volunteers as well as in patients have revealed that BURINEX ® is excreted in the urine. INDICATIONS: BURINEX ® is indicated for the treatment of oedema, eg. that associated with congestive heart failure, renal disease, acute pulmonary oedema, hepatic ascites. BURINEX ® injection may also be given intravenously or intramuscularly to those patients who are unable to take BURINEX ® tablets or who fail to respond satisfactorily to oral therapy. CONTRA-INDICATIONS: Anuria. Although BURINEX can be used to induce Прочетете целия документ